Gsk Share Discussion Threads

[tradermichael] 27/6/2023 15:53

Unbelievable!

[abdullla] 27/6/2023 10:24

All good news but no effects

[tradermichael] 26/6/2023 08:23

GSK said Monday that its shingles vaccine Shingrix has been approved by Japan's Health, Labor and Welfare Ministry, or MHLW, for the prevention of shingles in adults aged 18 years and over who are at increased risk of the condition.

The London-listed pharmaceutical giant said the approval represents a significant expansion of Shingrix's availability in Japan after it was first authorized in 2018 for shingles prevention in adults aged 50 and over.

"The MHLW approval was granted based on data from six clinical trials involving adults aged 18 years and over who were among those at increased risk for shingles, including those who had undergone recent stem cell transplantation or kidney transplant, or who had blood cancer, solid tumors or HIV," the company said.

[tradermichael] 26/6/2023 08:22

GSK said Monday that its chronic kidney disease treatment, daprodustat, has received an authorization recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP.

The London-listed pharmaceutical giant said the recommendation is for the use of daprodustat for symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis.

The company said the positive CHMP opinion was based on data from three global Phase 3 trials in dialysis patients from the Ascend clinical trial program.

[zho] 23/6/2023 15:47

According to analysts at Shore Capital, the settlement suggests “the company is willing to make settlements on a case-by-case basis to try to clear the current overhang”. A Florida judge threw out thousands of Zantac cancer claims last December. GSK’s shares were up more than 6 per cent by mid-morning, though volatility is likely to persist until all claims are resolved.

[tuftymatt] 23/6/2023 15:17

Yeah they have not done this to open the flood gates for every man and his dog to then file / expect a hand out.

This is a controlled move in the interests of the company in my opinion.

[tradermichael] 23/6/2023 15:14

The agreement means it will avoid a scheduled trial in California in July. Analysts at Citi said the settlement took one of the strongest cases against GSK off the table and created a precedent that could help with future cases.

[alibizzle] 23/6/2023 14:36

Hard to see where it goes now with share price , was hoping to get to £17-18 to pre zantac crash to break even , wish GSK hadn't settled as will be thousands more now so going to take half a billion plus time to sort , was hoping a good result end of July in court in California would have been better .

[halfpenny] 23/6/2023 14:31

Phew...!! Glad i sold and now further falls to come. It could go into negative..

I see profit takers moving in as there is still a Huge Risk.

This is only One case BUT there are many more in the pipeline and Now encouraged to Claim as they know GSK will settle.

Huge Risk ahead as many More Claims made!!

[panache1] 23/6/2023 14:24

Worth topping up ?

[pugugly] 23/6/2023 14:16

Bounce seems to be exhausted - Now falling fast -

[abdullla] 23/6/2023 13:30

Old habits die hard,Will it resume the old trading patterns

[tradermichael] 23/6/2023 12:32

This morning's bounce to 1434p has added £3.2 billion to the 'value' of GSK today (so far ..... )

[tradermichael] 23/6/2023 11:51

Not really, as the one in Canada faltered on 12 May (and this was a 'Class' action):

The company said in a statement that it “welcomed the decision” of the British Columbia Supreme Court to dismiss a proposed class action suit on behalf of Canadian Zantac users.

A Vancouver man filed the lawsuit in 2020, alleging that his use of the heartburn med from 2018 to 2019 caused him to develop cancer. His complaint named more than a dozen companies as defendants, including Sandoz Canada and GSK.

But the court dismissed the case due to “the uncontroverted evidence that neither ranitidine nor NDMA are reliably associated with increased cancer risk,” GSK said in its statement.

[halfpenny] 23/6/2023 11:22

I see profit takers moving in as there is still a Huge Risk.

This is only One case BUT there are many more in the pipeline and Now encouraged to Claim as they know GSK will settle.

Huge Risk ahead as many More Claims made!!

[lovewinshatelosses] 23/6/2023 11:06

Well, you can have mine today for 20 quid if you want? 10% discount for you. Today only...special price :)

[tradermichael] 23/6/2023 10:58

With all the good product news that has been bypassed by the 'market' while this charade has been played, the price should be 2200p ..... ;0)

[lovewinshatelosses] 23/6/2023 10:40

Well, whatever the rights or wrongs of them having settled (admit a part of me would also have rather they had refused to back down whatsoever) - I can see the commercial logic of such pragmatism.
So, it seems, does the market.
Hopefully this indeed will drive the share price back over 15 quid in short order. Might see some profit taking first, but it will be interesting to see what happens when the US opens. Might provide a second leg up. Hope so anyway :)

[montyhedge] 23/6/2023 10:16

That's a big relief, now investors who were scared off, probably come in now.

[geckotheglorious] 23/6/2023 09:58

GARYCOOK
Post 32114
"£13M purchase last night of 954,198 shares, after hours. Think the buyer already knew about the Zantac settlement ?"


A dead cert.

[tradermichael] 23/6/2023 09:53

Erm ..... the massive hike in bank rate (timing is unreal) ..... ;0)

[deanmatlazin] 23/6/2023 09:49

The share price drop from £18 to £14 when litigation news came out. Now they have closed the case what stopping this one to go above £16 today

[patientcapital] 23/6/2023 09:47

Nice end to the week!